FitLife Brands ROE 2010-2023 | FTLF
Current and historical return on equity (ROE) values for FitLife Brands (FTLF) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| FitLife Brands ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2023-12-31 | $0.01B | $0.03B | 20.41% |
| 2023-09-30 | $0.00B | $0.03B | 17.39% |
| 2023-06-30 | $0.00B | $0.02B | 13.48% |
| 2023-03-31 | $0.00B | $0.02B | 9.41% |
| 2022-12-31 | $0.00B | $0.02B | 14.63% |
| 2022-09-30 | $0.00B | $0.02B | 20.51% |
| 2022-06-30 | $0.00B | $0.02B | 22.22% |
| 2022-03-31 | $0.01B | $0.02B | 29.85% |
| 2021-12-31 | $0.01B | $0.02B | 32.26% |
| 2021-09-30 | $0.01B | $0.02B | 70.18% |
| 2021-06-30 | $0.01B | $0.02B | 93.62% |
| 2021-03-31 | $0.01B | $0.01B | 97.30% |
| 2020-12-31 | $0.01B | $0.01B | 128.57% |
| 2020-09-30 | $0.00B | $0.01B | 63.16% |
| 2020-06-30 | $0.00B | $0.01B | 47.06% |
| 2020-03-31 | $0.00B | $0.01B | 75.00% |
| 2019-12-31 | $0.00B | $0.00B | 80.00% |
| 2019-09-30 | $0.00B | $0.00B | 85.71% |
| 2019-06-30 | $0.00B | $0.00B | 66.67% |
| 2019-03-31 | $0.00B | $0.00B | 44.44% |
| 2018-12-31 | $0.00B | $0.00B | 0.00% |
| 2018-09-30 | $-0.01B | $0.00B | -640.00% |
| 2018-06-30 | $-0.01B | $0.00B | -300.00% |
| 2018-03-31 | $-0.01B | $0.00B | -190.48% |
| 2017-12-31 | $-0.01B | $0.00B | -133.33% |
| 2017-09-30 | $-0.00B | $0.01B | -30.00% |
| 2017-06-30 | $-0.00B | $0.01B | -18.60% |
| 2017-03-31 | $0.00B | $0.01B | 0.00% |
| 2016-12-31 | $0.00B | $0.01B | 8.70% |
| 2016-09-30 | $0.00B | $0.01B | 0.00% |
| 2016-06-30 | $0.00B | $0.01B | 0.00% |
| 2016-03-31 | $-0.00B | $0.01B | -11.43% |
| 2015-12-31 | $-0.00B | $0.01B | -25.81% |
| 2015-09-30 | $-0.00B | $0.01B | -14.29% |
| 2015-06-30 | $0.00B | $0.01B | 0.00% |
| 2015-03-31 | $0.00B | $0.01B | 14.29% |
| 2014-12-31 | $0.00B | $0.01B | 29.63% |
| 2014-09-30 | $0.00B | $0.01B | 48.00% |
| 2014-06-30 | $0.00B | $0.01B | 34.78% |
| 2014-03-31 | $0.00B | $0.01B | 17.39% |
| 2013-12-31 | $0.00B | $0.01B | 16.67% |
| 2013-09-30 | $0.00B | $0.01B | 32.00% |
| 2013-06-30 | $0.00B | $0.01B | 32.00% |
| 2013-03-31 | $0.00B | $0.01B | 52.17% |
| 2012-12-31 | $0.00B | $0.01B | 60.00% |
| 2012-09-30 | $0.00B | $0.01B | 47.06% |
| 2012-06-30 | $0.00B | $0.01B | 50.00% |
| 2012-03-31 | $0.00B | $0.00B | 28.57% |
| 2011-12-31 | $0.00B | $0.00B | 0.00% |
| 2011-09-30 | $-0.00B | $0.00B | -61.54% |
| 2011-06-30 | $-0.00B | $0.00B | -133.33% |
| 2011-03-31 | $-0.00B | $0.00B | -200.00% |
| 2010-12-31 | $-0.00B | $0.00B | -533.33% |
| 2010-09-30 | $-0.01B | inf% | |
| 2010-06-30 | $-0.01B | inf% | |
| 2010-03-31 | $-0.01B | inf% | |
| 2009-12-31 | $-0.01B | inf% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.129B | $0.053B |
| FitLife Brands, Inc. provides nutritional and fitness enhancement products for health-conscious consumers. The Company's product includes Pump Fuel, ACG3, Core Fuel, Embrace Extreme, Lipo Rush, Cardio Cuts, Dr. Detox, Dr. Cholesterol and Dr. Joints. It market and sells product directly to athletic facilities, gyms and independent retailers. Fitlife Brands, Inc., formerly known as Bond Laboratories Inc., is headquartered in Omaha, Nebraska. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $185.422B | 24.34 |
| Stryker (SYK) | United States | $128.275B | 31.81 |
| Boston Scientific (BSX) | United States | $107.479B | 34.23 |
| Medtronic (MDT) | Ireland | $105.230B | 14.90 |
| EssilorLuxottica (ESLOY) | France | $98.467B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.075B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.356B | 30.00 |
| ResMed (RMD) | United States | $26.979B | 25.30 |
| Terumo (TRUMY) | Japan | $24.775B | 34.99 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.604B | 15.84 |
| Baxter (BAX) | United States | $20.430B | 14.90 |
| Koninklijke Philips (PHG) | Netherlands | $19.242B | 15.35 |
| Insulet (PODD) | United States | $11.496B | 60.36 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.440B | 0.00 |
| Demant (WILYY) | Denmark | $9.943B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.860B | 23.42 |
| BellRing Brands (BRBR) | United States | $7.238B | 38.92 |
| Lantheus Holdings (LNTH) | United States | $4.470B | 11.54 |
| Haemonetics (HAE) | United States | $4.452B | 22.77 |
| Perrigo (PRGO) | Ireland | $4.238B | 12.12 |
| GN Store Nord (GNNDY) | Denmark | $3.889B | 25.18 |
| Prestige Consumer Healthcare (PBH) | United States | $3.482B | 16.47 |
| Envista Holdings (NVST) | United States | $3.441B | 13.09 |
| QuidelOrtho (QDEL) | United States | $2.654B | 9.63 |
| Neogen (NEOG) | United States | $2.591B | 24.92 |
| Green Thumb Industries (GTBIF) | United States | $2.482B | 78.67 |
| ICU Medical (ICUI) | United States | $2.303B | 17.19 |
| TG Therapeutics (TGTX) | United States | $2.150B | 695.50 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.906B | 0.00 |
| Owens & Minor (OMI) | United States | $1.848B | 17.74 |
| Agios Pharmaceuticals (AGIO) | United States | $1.780B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.617B | 0.00 |
| InMode (INMD) | Israel | $1.429B | 7.40 |
| LeMaitre Vascular (LMAT) | United States | $1.414B | 46.66 |
| National Vision Holdings (EYE) | United States | $1.399B | 43.58 |
| AdaptHealth (AHCO) | United States | $1.273B | 9.58 |
| Warby Parker (WRBY) | United States | $1.254B | 0.00 |
| AtriCure (ATRC) | United States | $1.094B | 0.00 |
| MacroGenics (MGNX) | United States | $0.899B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.872B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.764B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.686B | 14.82 |
| Cresco Labs (CRLBF) | United States | $0.674B | 0.00 |
| Evolus (EOLS) | United States | $0.664B | 0.00 |
| Jin Medical (ZJYL) | China | $0.608B | 0.00 |
| Quanterix (QTRX) | United States | $0.596B | 0.00 |
| Valneva SE (VALN) | France | $0.526B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.504B | 10.91 |
| PetIQ (PETQ) | United States | $0.480B | 17.93 |
| TerrAscend (TSNDF) | Canada | $0.462B | 0.00 |
| ZimVie (ZIMV) | United States | $0.421B | 25.80 |
| Biote (BTMD) | United States | $0.416B | 3.96 |
| OraSure Technologies (OSUR) | United States | $0.402B | 6.66 |
| Surmodics (SRDX) | United States | $0.373B | 40.26 |
| Aurora Cannabis (ACB) | Canada | $0.366B | 0.00 |
| Zynex (ZYXI) | United States | $0.352B | 40.52 |
| Viemed Healthcare (VMD) | United States | $0.310B | 30.81 |
| Cerus (CERS) | United States | $0.308B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.278B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.266B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.238B | 14.73 |
| Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.178B | 0.00 |
| Omeros (OMER) | United States | $0.177B | 0.00 |
| Veru (VERU) | United States | $0.177B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.162B | 0.00 |
| High Tide (HITI) | Canada | $0.161B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.156B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.141B | 70.99 |
| Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
| InterCure (INCR) | Israel | $0.120B | 20.31 |
| Fonar (FONR) | United States | $0.107B | 9.16 |
| MariMed (MRMD) | United States | $0.100B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.089B | 0.00 |
| Safety Shot (SHOT) | United States | $0.082B | 0.00 |
| Brainsway (BWAY) | Israel | $0.080B | 0.00 |
| Chimerix (CMRX) | United States | $0.079B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.059B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.055B | 3.59 |
| Apyx Medical (APYX) | United States | $0.051B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.95 |
| Bright Green (BGXX) | United States | $0.035B | 0.00 |
| Modular Medical (MODD) | United States | $0.033B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Flora Growth (FLGC) | United States | $0.020B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 74.09 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |